恩华药业

- 002262

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
恩华药业(002262) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入135,756.57504,150.45365,598.52240,032.88117,880.65
营业收入135,756.57504,150.45365,598.52240,032.88117,880.65
二、营业总成本103,680.83391,201.88266,005.44177,412.2290,969.11
营业成本39,670.69136,984.3198,315.8663,018.1331,440.37
营业税金及附加1,867.196,800.044,928.193,297.901,676.14
销售费用43,702.81173,700.41110,129.2778,256.5142,069.08
管理费用4,733.7320,711.5715,153.609,460.955,068.02
财务费用-635.57-1,926.09-992.69-399.60-252.15
研发费用14,341.9954,931.6338,471.2123,778.3310,967.66
资产减值损失----------
公允价值变动收益----------
投资收益1,138.715,104.353,731.372,524.061,586.75
其中:对联营企业和合营企业的投资收益421.71963.98540.25145.84513.86
汇兑收益----------
三、营业利润30,487.13118,234.42100,545.6962,609.2026,157.96
加:营业外收入182.28674.7263.58-12.21-102.23
减:营业外支出695.802,044.73531.78398.02205.76
其中:非流动资产处置损失----------
四、利润总额29,973.61116,864.41100,077.4862,198.9825,849.97
减:所得税费用3,509.7413,439.6811,736.027,758.143,332.63
五、净利润26,463.88103,424.7388,341.4754,440.8422,517.34
归属于母公司所有者的净利润26,528.22103,691.8188,564.1354,470.3022,742.94
少数股东损益-64.35-267.08-222.66-29.46-225.60
六、每股收益
基本每股收益(元/股)0.26001.03000.88000.54000.2300
稀释每股收益(元/股)0.26001.03000.88000.54000.2300
七、其他综合收益---634.89------
八、综合收益总额26,463.88102,789.8488,341.4754,440.8422,517.34
归属于母公司所有者的综合收益总额26,528.22103,056.9288,564.1354,470.3022,742.94
归属于少数股东的综合收益总额-64.35-267.08-222.66-29.46-225.60
下载全部历史数据到excel中 返回页顶